Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling Parkinson's Disease in C. elegans.

Jason F Cooper1, Jeremy M Van Raamsdonk1,2,3

  • 1Laboratory of Aging and Neurodegenerative Disease, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.

Journal of Parkinson'S Disease
|February 27, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple Molecular Pathways to Longevity: Opposing Gene Expression Programs Define Distinct Aging Strategies.

bioRxiv : the preprint server for biology·2026
Same author

A high-throughput, streamlined cloning protocol to generate guide RNAs for CRISPR activation.

Frontiers in genome editing·2026
Same author

Universal transcriptomic hallmarks of mammalian ageing and mortality.

Nature·2026
Same author

MAK-2 Kinase Is Required for Extended Longevity and Enhanced Stress Resistance Resulting From Mild Impairment of Mitochondrial Function in isp-1 Mutants.

Aging cell·2026
Same author

Mild mitochondrial impairment activates overlapping longevity pathways converging on the flavin-containing monooxygenase FMO-2.

Frontiers in aging·2026
Same author

Stress-associated High Production of Large Extracellular Vesicles in the Parent Generation is Not Inherited by&nbsp; <i>C. elegans</i> F1 Progeny.

microPublication biology·2026

The nematode worm C. elegans provides a powerful model for studying Parkinson's disease (PD). These models help researchers understand PD mechanisms and identify potential treatments by observing worm phenotypes.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder with unknown causes and no current neuroprotective treatments.
  • Accurate animal models are crucial for understanding PD pathogenesis and discovering therapeutic strategies.

Purpose of the Study:

  • This review examines the utility of Caenorhabditis elegans (C. elegans) as a model organism for Parkinson's disease research.
  • To highlight the advantages of C. elegans in studying PD mechanisms and identifying therapeutic targets.

Main Methods:

  • Review of existing C. elegans models for PD, including genetic and toxicant-induced models.
  • Discussion of C. elegans advantages: genetic tractability, rapid experimental cycles, cost-effectiveness, and suitability for large-scale screens.
Keywords:
ATP13A2C. elegansDJ-1PINK1Parkinson’s diseaseanimal modelgeneticsneurodegenerationparkinα-synuclein

Related Experiment Videos

  • Analysis of C. elegans models expressing alpha-synuclein, LRRK2, or exhibiting deletions in key PD-associated genes (PRKN, PINK1, DJ-1, ATP13A2).

    • Main Results:

    • C. elegans PD models display relevant phenotypes: dopamine neuron loss, behavioral deficits, stress sensitivity, protein aggregation, and movement impairment.
    • These phenotypes serve as measurable outcomes for investigating PD.
    • C. elegans models facilitate the identification of genetic modifiers and potential therapeutic targets.

    Conclusions:

    • C. elegans offers a valuable platform for dissecting Parkinson's disease mechanisms due to its experimental advantages.
    • This model system aids in the discovery of novel therapeutic targets for PD that can be further validated.
    • Utilizing C. elegans accelerates the understanding and potential treatment of Parkinson's disease.